An 85-year-old male presented at the Department of Dermatology of our institution with an erythematous plaque. He had been inoculated with pneumococcal vaccine (Pneumovax
® NP) three days earlier. The next day, he developed pain followed by redness at the vaccination site. A physical examination revealed dark reddish edematous erythema together with purpura on the lateral aspect of the left upper arm. He noted mild tenderness on pressure. The patient's white blood cell (WBC) count and differential WBC count demonstrated mild neutrophilia (WBC: 9,000/μl, neutrophils: 75.7%). Although a blood biochemistry panel, which included markers of renal and liver function, produced normal results, he exhibited an elevated C-reactive protein level of 4.51mg/dl. The erythema and pain disappeared three days after the topical application of betamethasone valerate + gentamicin sulfate (Rinderon
® VG) ointment. However, the patient subsequently developed a cutaneous ulcer at the injection site. The ulcerative lesion subsided, leaving a scar, after 4 months' sulfadiazine silver (Geben
®) cream. On the basis of the patient's morphological findings, we speculated that the pathogenesis of this case involved inflammation of the dermis and subcutaneous tissue. Phlegmon might be caused by a different mechanism because it exhibits a different clinical course to that seen in the present case. Clinicians should be aware of such adverse effects of pneumococcal vaccinations, the use of which is increasing in Japan.Skin Research, 15: 270-273, 2016
View full abstract